Methodology of an international study of people with multiple sclerosis recruited through web 2.0 platforms: Demographics, lifestyle, and disease characteristics

Neurology Research International

Volumn 2013, Issue , 2013, Pages

  Hadgkiss, Emily J ^a   Jelinek, George A ^a,b   Weiland, Tracey J ^a   Pereira, Naresh G ^c   Marck, Claudia H ^a   Van Der Meer, Dania M ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF NOTRE DAME   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DEMOGRAPHY; DISEASE ACTIVITY; FEMALE; HEALTH SURVEY; HUMAN; LIFESTYLE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT;

EID: 84877272618     PISSN: 20901852     EISSN: 20901860     Source Type: Journal    
DOI: 10.1155/2013/580596     Document Type: Article

References (63)

1. Marrie R. A., Environmental risk factors in multiple sclerosis aetiology. The Lancet Neurology 2004 3 12 709 718 2-s2.0-8844239964 10.1016/S1474-4422(04) 00933-0 (Pubitemid 39535256)
2. Flachenecker P., Stuke K., National MS registries. Journal of Neurology 2008 255 6 102 108 2-s2.0-64149092288 10.1007/s00415-008-6019-5
3. D'Hooghe M. B., Nagels G., Bissay V., de Keyser J., Modifiable factors influencing relapses and disability in multiple sclerosis. Multiple Sclerosis 2010 16 7 773 785 2-s2.0-77955017653 10.1177/1352458510367721
4. Marrie R. A., Demographic, genetic, and environmental factors that modify disease course. Neurologic Clinics 2011 29 2 323 341 2-s2.0-79952848048 10.1016/j.ncl.2010.12.004
5. Jelinek G., Taking Control of Multiple Sclerosis: Natural and Medical Therapies to Prevent Its Progression 2005 Lancaster, UK Fleetbooks
6. Hadgkiss E. J., Jelinek G. A., Weiland T. J., Rumbold G., Mackinlay C. A., Gutbrod S., Gawler I., Health-related quality of life outcomes at 1 and 5 years after a residential retreat promoting lifestyle modification for people with multiple sclerosis. Neurological Sciences 2013 34 2 187 195
7. Jelinek G., Overcoming Multiple Sclerosis: An Evidence-Based Guide to Recovery 2010 Sydney, Australia Allen and Unwin
8. 'Hooghe M. B. D., Haentjens P., Nagels G., de Keyser J., Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis. The European Journal of Neurology 2012 19 4 616 624
9. Kuehn B. M., Patients go online seeking support, practical advice on health conditions. Journal of the American Medical Association 2011 305 16 1644 1645 2-s2.0-79955408840 10.1001/jama.2011.509
10. Lee B. K., Epidemiologic research and Web 2.0-the user-driven Web. Epidemiology 2010 21 6 760 763 2-s2.0-77958506242 10.1097/EDE.0b013e3181f5a75f
11. Stromgren C., Community outreach through web resources: multiple sclerosis. Medical Reference Services Quarterly 2002 21 1 61 70 2-s2.0-11244301223 10.1300/J115v21n01-05 (Pubitemid 41586900)
12. Hohol M. J., Orav E. J., Weiner H. L., Disease steps in multiple sclerosis: a simple approach to evaluate disease progression. Neurology 1995 45 2 251 255 2-s2.0-0028817189
13. Sangha O., Stucki G., Liang M. H., Fossel A. H., Katz J. N., The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Care and Research 2003 49 2 156 163 2-s2.0-0345269751 (Pubitemid 36418272)
14. Vickrey B. G., Hays R. D., Harooni R., Myers L. W., Ellison G. W., A health-related quality of life measure for multiple sclerosis. Quality of Life Research 1995 4 3 187 206 2-s2.0-0029000541 10.1007/BF02260859
15. McKellar S., Horsley P., Chambers R., Pullen M., Vandersee P., Clarke C., Callum H., Bauer J. D., Development of the diet habits questionnaire for use in cardiac rehabilitation. Australian Journal of Primary Health 2008 14 3 43 47 2-s2.0-58149337388
16. Craig C. L., Marshall A. L., Sjöström M., Bauman A. E., Booth M. L., Ainsworth B. E., Pratt M., Ekelund U., Yngve A., Sallis J. F., Oja P., International physical activity questionnaire: 12-country reliability and validity. Medicine and Science in Sports and Exercise 2003 35 8 1381 1395 2-s2.0-0042855872 10.1249/01.MSS.0000078924.61453.FB (Pubitemid 36936159)
17. Blake R. L., McKay D. A., A single-item measure of social supports as a predictor of morbidity. Journal of Family Practice 1986 22 1 82 84 2-s2.0-0022629970 (Pubitemid 16230412)
18. Krupp L. B., LaRocca N. G., Muir-Nash J., Steinberg A. D., The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of Neurology 1989 46 10 1121 1123 2-s2.0-0024420189 (Pubitemid 19246303)
19. Kroenke K., Spitzer R. L., Williams J. B. W., The patient health questionnaire-2: validity of a two-item depression screener. Medical Care 2003 41 11 1284 1292 2-s2.0-0642311548 10.1097/01.MLR.0000093487.78664.3C
20. Australian Bureau of Statistics, Australian standard classification of cultural and ethnic groups. 2012, http://www.abs.gov.au/AUSSTATS/abs@nsf/ DetailsPage/1249. 02011?OpenDocument
21. Hohol M. J., Orav E. J., Weiner H. L., Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression. Multiple Sclerosis 1999 5 5 349 354 2-s2.0-0032749804 (Pubitemid 29505050)
22. Marrie R. A., Cutter G., Tyry T., Hadjimichael O., Campagnolo D., Vollmer T., Changes in the ascertainment of multiple sclerosis. Neurology 2005 65 7 1066 1070 2-s2.0-26444454498 10.1212/01.wnl.0000178891.20579.64 (Pubitemid 41429632)
23. Marrie R. A., Cutter G., Tyry T., Vollmer T., Campagnolo D., Does multiple sclerosis-associated disability differ between races? Neurology 2006 66 8 1235 1240 2-s2.0-33646685266 10.1212/01.wnl.0000208505.81912.82 (Pubitemid 43739710)
24. Hadjimichael O., Vollmer T., Oleen-Burkey M. K., Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey. Health and Quality of Life Outcomes 2008 6, article 100 2-s2.0-57649201559 10.1186/1477-7525-6-100
25. Holper L., Coenen M., Weise A., Stucki G., Cieza A., Kesselring J., Characterization of functioning in multiple sclerosis using the ICF. Journal of Neurology 2010 257 1 103 113 2-s2.0-74849106195 10.1007/s00415-009-5282-4
26. Solari A., Filippini G., Mendozzi L., Ghezzi A., Cifani S., Barbieri E., Baldini S., Salmaggi A., La Mantia L., Farinotti M., Caputo D., Mosconi P., Validation of Italian multiple sclerosis quality of life 54 questionnaire. Journal of Neurology Neurosurgery and Psychiatry 1999 67 2 158 162 2-s2.0-0032774670 (Pubitemid 29326944)
27. Yamamoto T., Ogata K., Katagishi M., Shimizu H., Ogawa M., Yamamura T., Kawai M., Validation of the Japanese-translated version multiple sclerosis quality of life-54 instrument. Clinical Neurology 2004 44 7 417 421 2-s2.0-11144305397 (Pubitemid 40036636)
28. Acquardo C., Lafortune L., Mear I., Quality of life in multiple sclerosis: translation in French Canadian of the MSQoL-54. Health and Quality of Life Outcomes 2003 1 article 70 2-s2.0-4243090415 10.1186/1477-7525-1-70 (Pubitemid 39111926)
29. Amato M. P., Ponziani G., Rossi F., Liedl C. L., Stefanile C., Rossi L., Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Multiple Sclerosis 2001 7 5 340 344 2-s2.0-0034750269 10.1191/135245801681138059 (Pubitemid 33026260)
30. Wang J. L., Reimer M. A., Metz L. M., Patten S. B., Major depression and quality of life in individuals with multiple sclerosis. International Journal of Psychiatry in Medicine 2000 30 4 309 317 2-s2.0-0034461987 10.2190/PGWT-UXJ0- 7UEH-LGRY (Pubitemid 32238564)
31. Tepavcevic D. K., Kostic J., Basuroski I. D., Stojsavljevic N., Pekmezovic T., Drulovic J., The impact of sexual dysfunction on the quality of life measured by MSQoL-54 in patients with multiple sclerosis. Multiple Sclerosis 2008 14 8 1131 1136 2-s2.0-58149333787 10.1177/1352458508093619
32. Stroud N., Minahan C., Sabapathy S., The perceived benefits and barriers to exercise participation in persons with multiple sclerosis. Disability and Rehabilitation 2009 31 26 2216 2222 2-s2.0-70449638119 10.3109/09638280902980928
33. Weikert M., Motl R. W., Suh Y., McAuley E., Wynn D., Accelerometry in persons with multiple sclerosis: measurement of physical activity or walking mobility? Journal of the Neurological Sciences 2010 290 1-2 6 11 2-s2.0-74849133690 10.1016/j.jns.2009.12.021
34. Reavley N., Pallant J. F., Sali A., Evaluation of the effects of a psychosocial intervention on mood, coping, and quality of life in cancer patients. Integrative Cancer Therapies 2009 8 1 47 55 2-s2.0-61849084234 10.1177/1534735408329411
35. Koopman C., Nouriani B., Erickson V., Anupindi R., Butler L. D., Bachmann M. H., Sephton S. E., Spiegel D., Sleep disturbances in women with metastatic breast cancer. Breast Journal 2002 8 6 362 370 2-s2.0-0036848929 10.1046/j.1524-4741.2002.08606.x (Pubitemid 35334651)
36. Smedal T., Beiske A. G., Glad S. B., Myhr K. M., Aarseth J. H., Svensson E., Gjelsvik B., Strand L. I., Fatigue in multiple sclerosis: associations with health-related quality of life and physical performance. The European Journal of Neurology 2011 18 1 114 120 2-s2.0-78650078037 10.1111/j.1468-1331.2010.03090.x
37. Lerdal A., Celius E. G., Moum T., Fatigue and its association with sociodemographic variables among multiple sclerosis patients. Multiple Sclerosis 2003 9 5 509 514 2-s2.0-0142091820 10.1191/1352458503ms943oa (Pubitemid 37287732)
38. Marrie R. A., Cutter G., Tyry T., Hadjimichael O., Campagnolo D., Vollmer T., Validation of the NARCOMS registry: fatique assessment. Multiple Sclerosis 2005 11 5 583 584 2-s2.0-25844471632 10.1191/1352458505ms1216oa (Pubitemid 41387704)
39. Sjonnesen K., Berzins S., Fiest K. M., Bulloch A. G., Metz L. M., Thombs B. D., Patten S. B., Evaluation of the 9-item Patient Health Questionnaire (PHQ-9) as an assessment instrument for symptoms of depression in patients with multiple sclerosis. Postgraduate Medicine 2012 124 5 69 77
40. Alonso A., Hernán M. A., Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 2008 71 2 129 135 2-s2.0-47549090868 10.1212/01.wnl.0000316802.35974.34
41. Rhodes S. D., Bowie D. A., Hergenrather K. C., Collecting behavioural data using the world wide web: considerations for researchers. Journal of Epidemiology and Community Health 2003 57 1 68 73 2-s2.0-0037221207 10.1136/jech.57.1.68 (Pubitemid 36054878)
42. Cutler D. M., Lleras-Muney A., Education and health: evaluating theories and evidence. Working Paper No. 2006 12352 Massachusetts, Mass, USA National Bureau of Economic Research
43. Stepleman L., Rutter M. C., Hibbard J., Johns L., Wright D., Hughes M., Validation of the patient activation measure in a multiple sclerosis clinic sample and implications for care. Disability and Rehabilitation 2010 32 19 1558 1567 2-s2.0-77955066029 10.3109/09638280903567885
44. Hopman W. M., Coo H., Edgar C. M., McBride E. V., Day A. G., Brunet D. G., Factors associated with health-related quality of life in multiple sclerosis. The Canadian Journal of Neurological Sciences 2007 34 2 160 166 2-s2.0-34347262396 (Pubitemid 47000117)
45. Kister I., Chamot E., Cutter G., Bacon T. E., Jokubaitis V. G., Hughes S. E., Gray O. M., Trojano M., Izquierdo G., Grand'Maison F., Duquette P., Lugaresi A., Grammond P., Boz C., Hupperts R., Petersen T., Giuliani G., Oreja-Guevara C., Iuliano G., Lechner-Scott J., Bergamaschi R., Rio M. E., Verheul F., Fiol M., van Pesch V., Slee M., Butzkueven H., Herbert J., Increasing age at disability milestones among MS patients in the MSBase Registry. Journal of the Neurological Sciences 2012 318 1-2 94 99
46. Miller D., Rudick R. A., Hutchinson M., Patient-centered outcomes translating clinical efficacy into benefits on health-related quality of life. Neurology 2010 74 supplement 3 S24 S35 2-s2.0-77951685116 10.1212/WNL. 0b013e3181dbb884
47. Patten S. B., Beck C. A., Williams J. V. A., Barbui C., Metz L. M., Major depression in multiple sclerosis: a population-based perspective. Neurology 2003 61 11 1524 1527 2-s2.0-0345168864 (Pubitemid 37505573)
48. Siegert R. J., Abernethy D. A., Depression in multiple sclerosis: a review. Journal of Neurology, Neurosurgery and Psychiatry 2005 76 4 469 475 2-s2.0-16844385525 10.1136/jnnp.2004.054635 (Pubitemid 40486568)
49. Marrie R. A., Horwitz R., Cutter G., Tyry T., Campagnolo D., Vollmer T., High frequency of adverse health behaviors in multiple sclerosis. Multiple Sclerosis 2009 15 1 105 113 2-s2.0-58149087356 10.1177/1352458508096680
50. Skovgaard L., Nicolajsen P. H., Pedersen E., Kant M., Fredrikson S., Verhoef M., Meyrowitsch D. W., Use of complementary and alternative medicine among people with multiple sclerosis in the Nordic countries. Autoimmune Diseases 2012 2012 13 841085 10.1155/2012/841085
51. Schwarz S., Knorr C., Geiger H., Flachenecker P., Complementary and alternative medicine for multiple sclerosis. Multiple Sclerosis 2008 14 8 1113 1119 2-s2.0-57949105485 10.1177/1352458508092808
52. Shinto L., Yadav V., Morris C., Lapidus J. A., Senders A., Bourdette D., Demographic and health-related factors associated with complementary and alternative medicine (CAM) use in multiple sclerosis. Multiple Sclerosis 2006 12 1 94 100 2-s2.0-31644438191 10.1191/1352458506ms1230oa (Pubitemid 43169243)
53. Jelinek G. A., Hassed C. S., Managing multiple sclerosis in primary care: are we forgetting something? Quality in Primary Care 2009 17 1 55 61 2-s2.0-63049136103
54. Li M. P. M., Jelinek G. A., Weiland T. J., Mackinlay C. A., Dye S., Gawler I., Mcouns H. S., Effect of a residential retreat promoting lifestyle modifications on health-related quality of life in people with multiple sclerosis. Quality in Primary Care 2010 18 6 379 389 2-s2.0-79952128453
55. Dworkin R. H., Bates D., Millar J. H. D., Paty D. W., Linoleic acid and multiple sclerosis: a reanalysis of three double-blind trials. Neurology 1984 34 11 1441 1445 2-s2.0-0021160668 (Pubitemid 14024281)
56. Hibbard J. H., Mahoney E. R., Stock R., Tusler M., Do increases in patient activation result in improved self-management behaviors? Health Services Research 2007 42 4 1443 1463 2-s2.0-34347394935 10.1111/j.1475-6773.2006.00669. x (Pubitemid 47024845)
57. Riazi A., Thompson A. J., Hobart J. C., Self-efficacy predicts self-reported health status in multiple sclerosis. Multiple Sclerosis 2004 10 1 61 66 2-s2.0-0347968010 10.1191/1352458504ms986oa (Pubitemid 38100528)
58. Mosen D. M., Schmittdiel J., Hibbard J., Sobel D., Remmers C., Bellows J., Is patient activation associated with outcomes of care for adults with chronic conditions? Journal of Ambulatory Care Management 2007 30 1 21 29 2-s2.0-33845773384 (Pubitemid 46005839)
59. Wicks P., Massagli M., Frost J., Brownstein C., Okun S., Vaughan T., Bradley R., Heywood J., Sharing health data for better outcomes on patientslikeme. Journal of Medical Internet Research 2010 12 2, article e19 2-s2.0-77953856664 10.2196/jmir.1549
60. Mendelson C., Recruiting participants for research from online communities. Computers Informatics Nursing 2007 25 6 317 323 2-s2.0-36249027124 10.1097/01.NCN.0000299653.13777.51
61. Marrie R. A., Cutter G., Tyry T., Campagnolo D., Vollmer T., Validation of the NARCOMS registry: diagnosis. Multiple Sclerosis 2007 13 6 770 775 2-s2.0-34447508243 10.1177/1352458506075031 (Pubitemid 47074101)
62. Gold S. M., Schulz H., Mönch A., Schulz K. H., Heesen C., Cognitive impairment in multiple sclerosis does not affect reliability and validity of self-report health measures. Multiple Sclerosis 2003 9 4 404 410 2-s2.0-0042624767 10.1191/1352458503ms927oa (Pubitemid 36958025)
63. Ingram G., Colley E., Ben-Shlomo Y., Cossburn M., Hirst C. L., Pickersgill T. P., Robertson N. P., Validity of patient-derived disability and clinical data in multiple sclerosis. Multiple Sclerosis 2010 16 4 472 479 2-s2.0-77954687780 10.1177/1352458509358902